We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cassava Sciences Inc | NASDAQ:SAVA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.18 | -0.81% | 21.96 | 21.89 | 22.07 | 22.25 | 21.89 | 22.20 | 1,051,102 | 00:58:39 |
Lindsay Burns, PhD, Senior VP Neuroscience, will provide a pre-recorded, 10-minute overview of Cassava Sciences’ program in Alzheimer’s disease during this event. A link for this webcast will be available on Cassava Sciences’ website on Wednesday, April 28th starting 8:30AM Eastern time and will remain there for approximately 90 days thereafter.
About Cassava Sciences, Inc.Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease. For more information, please visit: https://www.CassavaSciences.com.
For More Information Contact: Eric Schoen, Chief Financial Officereschoen@CassavaSciences.com(512) 501-2450
1 Year Cassava Sciences Chart |
1 Month Cassava Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions